Journals / Tüberküloz ve Toraks / 2021 / Cilt: 69 - Sayı: 2

An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome

SARS-CoV-2 enfeksiyonunun olağandışı seyri: Guillain-Barré sendromunun zorlu teşhisi

Pages
242–246
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurological and other complications which may arise during the course of critical illness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported.
📊
Key Findings & Data:In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course.
💡
Conclusion & Impact:It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurological and other complications which may arise during the course of critical illness.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus-2, typically presents with respiratory symptoms and fever, but still a variety of clinical presentations have been reported. In this study, it was aimed to report a case of COVID-19 with an atypical presentation and an atypical course. As well, the recovery phase was complicated with GBS and consequently cytomegalovirus infection. It should be kept in mind that patients with COVID-19 severe disease need to be followed for neurological and other complications which may arise during the course of critical illness.

Özet

COVID-19 tipik olarak solunum semptomları ve ateşle kendini göstermekte bununla beraber çeşitli klinik bulgular bildirilmiştir. Atipik bir başlangıç ve atipik bir seyir ile takip edilen COVID-19 vakası bildiriyoruz. Ayrıca iyileşme süreci de GBS ve eş zamanlı sitomegalovirüs enfeksiyonu ile seyretti. Ağır COVID-19 hastalarının kritik hastalık seyrinde ortaya çıkabilecek nörolojik ve diğer komplikasyonlar açısından takip edilmesi gerektiği unutulmamalıdır

🔖

Cite This Article

ALTINTAŞ, N. D., KARAHAN, Z. C., EVREN, E., ÇINAR, G., KOCA, A., GÜNALP, M., TALAN, L., ŞENER, Ö., ŞAHİN, T. (2022). An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barré Syndrome. Tüberküloz ve Toraks, Cilt: 69 - Sayı: 2, 242–246. https://ajindex.com/articles/618314

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Centers for Disease Control and Prevention (CDC). Ending home isolation for persons with COVID-19 not in healthcare settings. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html (Accessed date: 23.03.2020)
  2. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San PedroMurillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology 2020; 95(5): e601-e605
  3. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020; 19(5): 383-4
  4. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barre Syndrome associated with SARS-CoV-2. N Engl J Med 2020; 382(26): 2574-6
  5. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gonh MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020: 1-34
  6. Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy 2020; 75(7): 1699-1709
  7. Wakerley BR, Yuki N. Mimics and chameleons in GuillainBarre and Miller Fisher syndromes. Pract Neurol 2015; 15(2): 90-9
  8. Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med, 2020; 382(23): 2268-70
  9. Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020; 133(9): 1039-43
  10. Li Y, Hu Y, Yu Y, Zhang X, Li B, Wu J, et al. Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China. J Med Virol 2020; 92(10): 1938-47
  11. Chu CM, Leung WS, Cheng VC, Chan KH, Lin AWN, Chan VL, et al. Duration of RT-PCR positivity in severe acute respiratory syndrome. Eur Respir J 2005; 25(1): 12-4.